user

Anti-Axl antibody treatment reduces the severity of experimental autoimmune encephalomyelitis

被引：0
|
作者：
Juwen C. DuBois
Alex K. Ray
Peter Davies
Bridget Shafit-Zagardo
机构：
[1] Albert Einstein College of Medicine,Department of Pathology
[2] Albert Einstein College of Medicine,Department of Microbiology and Immunology
[3] Feinstein Institute for Medical Research,North Shore
来源：
Journal of Neuroinflammation | / 17卷
关键词：
α; Axl antibody; EAE; TAM activation; Demyelination; Microglia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Effect of hematopoietic growth factors on severity of experimental autoimmune encephalomyelitis
    Verda, L.
    Luo, K.
    Kim, D-A
    Bronesky, D.
    Kohm, A. P.
    Miller, S. D.
    Statkute, L.
    Oyama, Y.
    Burt, R. K.
    BONE MARROW TRANSPLANTATION, 2006, 38 (06) : 453 - 460
  • [42] Ketogenic diet decreases severity of experimental autoimmune encephalomyelitis.
    Kraus, M.
    Jiraskova, Zakostelska Z.
    Kostovcikova, K.
    Jackova, Z.
    Thon, T.
    Vavreckova, M.
    Vancikova, S.
    Udoumoh, A. F.
    Tlaskalova-Hogenova, H.
    Kverka, M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 : 126 - 126
  • [43] Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity
    Nath, Narender
    Khan, Musfiquidin
    Rattan, Ramandeep
    Mangalam, Ashutosh
    Makkar, Randhir S.
    de Meester, Carloe
    Bertrand, Luc
    Singh, Inderjit
    Chen, Yingjie
    Viollet, Benoit
    Giri, Shailendra
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 386 (01) : 16 - 20
  • [44] Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis
    Koch, Marcus W.
    Zabad, Rana
    Giuliani, Fabrizio
    Hader, Walter, Jr.
    Lewkonia, Ray
    Metz, Luanne
    Yong, V. Wee
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 358 (1-2) : 131 - 137
  • [45] Effect of hematopoietic growth factors on severity of experimental autoimmune encephalomyelitis
    L Verda
    K Luo
    D-A Kim
    D Bronesky
    A P Kohm
    S D Miller
    L Statkute
    Y Oyama
    R K Burt
    Bone Marrow Transplantation, 2006, 38 : 453 - 460
  • [46] The TLR7 agonist, imiquimod, increases IFN-β production and reduces the severity of experimental autoimmune encephalomyelitis
    O'Brien, Kate
    Fitzgerald, Denise
    Rostami, Abdolmohamad
    Gran, Bruno
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 221 (1-2) : 107 - 111
  • [47] Oral fingolimod (FTY720) reduces the severity of experimental autoimmune encephalomyelitis and protects against disease progression
    Schubart, Anna
    Seabrook, Tim
    Rausch, Martin
    Mir, Anis K.
    MULTIPLE SCLEROSIS, 2008, 14 : S54 - S55
  • [48] Prophylactic exposure to oral riluzole reduces the clinical severity and immune-related biomarkers of experimental autoimmune encephalomyelitis
    Rotolo, Renee A.
    Demuro, Jennifer
    Drummond, Gregory
    Little, Casey
    Johns, Lennart D.
    Betz, Adrienne J.
    JOURNAL OF NEUROIMMUNOLOGY, 2021, 356
  • [49] Vitamin D3-induced IDO+ Tolerogenic DCs Reduces the Severity of Experimental Autoimmune Encephalomyelitis
    Farias, Alessandro S.
    Spagnol, Gabriela S.
    Pradella, Fernando
    Santos, Mariana P. A.
    Moraes, Adriel S.
    Oliveira, Elaine C.
    Longhini, Ana Leda F.
    de Paula, Rosemeire F. O.
    Santos, Leonilda M. B.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1872 - 1873
  • [50] Deletion of UCP2 in iNOS Deficient Mice Reduces the Severity of the Disease during Experimental Autoimmune Encephalomyelitis
    Aheng, Caroline
    Ly, Nathalie
    Kelly, Mairead
    Ibrahim, Saleh
    Ricquier, Daniel
    Alves-Guerra, Marie-Clotilde
    Miroux, Bruno
    PLOS ONE, 2011, 6 (08):
12345